Skip to main content
. 2016 Feb 24;7(13):16384–16395. doi: 10.18632/oncotarget.7650

Figure 6. Analysis of the progression-free survival based on the different evolution patterns of gliomas.

Figure 6

There was no difference in the progression-free survival when LGG malignantly recurred to LGG, AG or GBM (Median PFS = 802 days, 830 days and 835 days, respectively, (A). However, the time interval of AG to GBM was significantly shorter than that of AG to AG (Median PFS = 365 days and 611 days, respectively, p = 0.0067, log-rank test). The progressive time interval of GBM to GBM was similar to that of AG to GBM (Median PFS = 395 days, p = 0.8446, (B).